Professional manufacturer on medical needles and cannula

Hyaluronic Acid Dermal Filler

$0.00
CROSS-LINKED H.A FILLER WITH LIDOCAIN

Concentration:  20 mg/mL
Process:  Biphasic cross-linking, medium to large molecules
Needle:   25G/27G
Packaging:  1mL,2mL,5mL, 10mL or as specified by the customer

RAW MATERIAL CONTROL Full Process Control From Raw Materials to Product

  • Non animal origin, fermented by non genetically modified strains
  • High purity and low impurities
  • Sterile filling and 10000 level GMP cleaning workshop
  • Pass the CEP, Certificate of Suitability to European Pharmacopoeia
  • Approved NMPA APi by the State Food and Drug Administration
  • Drug Master File via FDA DMF in the United States

 

Product details

ACMISAWA is a top manufacturer and supplier offering hyaluronic acid filler (H.A filler) with the most renowned brands in the aesthetics field. Our supplying range includes well-known names such as Bellast, Masfill, Restylane and others. OEM/ODM for your brand is also available.

We maintain a vast inventory of aesthetic medical equipment, and thanks to our strong negotiating expertise and in-depth product knowledge, we’re able to provide highly competitive pricing.

The hyaluronic acid filler has below great characteristics for your choice.

Product

TECHNICAL

Dual Conduction Crosslink

  • Directional cross-linking: it is also cross-linked with carboxyl, hydroxyl, N-acetylamino and other active groups in the molecular structure of hyaluronic acid.
  • Gradient cross-linking: By changing the cross-linking sequence, temperature, and dosage, precise control of light, medium, and heavy cross-linking, as well as large, medium, and small particle sizes.
  • Effective crosslinking: BDDE crosslinking agent molecules crosslink two hyaluronic acid molecular chains together, minimizing ineffective suspension crosslinking.

Better Result

  • High Viscoelasticity, strong resilience and better support effect.
  • Hyaluronic acid molecules are more stable.
  • The degradation rate is slow and lasts for a long time.
  • Low crosslinking agent, high crosslinking degree, and low side effects.
References:

Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view https://pubmed.ncbi.nlm.nih.gov/34882503/

Recommendations for the treatment of tear trough deformity with cross-linked hyaluronic acid filler https://onlinelibrary.wiley.com/doi/10.1111/jocd.13475

Product Enquiry